000 01548 a2200469 4500
005 20250514031253.0
264 0 _c20020904
008 200209s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(01)02668-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuirado, L
245 0 0 _aUse of cytomegalovirus antigenemia as a marker for preemptive treatment.
_h[electronic resource]
260 _bTransplantation proceedings
_cFeb 2002
300 _a67-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAntigens, Viral
_xblood
650 0 4 _aBiomarkers
_xblood
650 0 4 _aCytomegalovirus Infections
_xdiagnosis
650 0 4 _aDrug Therapy, Combination
650 0 4 _aGanciclovir
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aInjections, Intravenous
650 0 4 _aKidney Transplantation
_ximmunology
650 0 4 _aPhosphoproteins
_xblood
650 0 4 _aPostoperative Complications
_xvirology
650 0 4 _aViral Matrix Proteins
_xblood
700 1 _aHerreros, M A
700 1 _aMuñoz, J M
700 1 _aRabella, N
700 1 _aFacundo, C
700 1 _aAgraz, I
700 1 _aDíaz, M
700 1 _aDiaz, J M
700 1 _aDurán, F
700 1 _aSolà, R
773 0 _tTransplantation proceedings
_gvol. 34
_gno. 1
_gp. 67-8
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(01)02668-9
_zAvailable from publisher's website
999 _c11861698
_d11861698